Core LaboratoriesCLB
CLB
About: Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Employees: 3,500
0
Funds holding %
of 7,202 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0.54% less ownership
Funds ownership: 108.22% [Q4 2024] → 107.68% (-0.54%) [Q1 2025]
9% less funds holding
Funds holding: 208 [Q4 2024] → 190 (-18) [Q1 2025]
14% less capital invested
Capital invested by funds: $880M [Q4 2024] → $756M (-$124M) [Q1 2025]
32% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 76
32% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 34
34% less call options, than puts
Call options by funds: $321K | Put options by funds: $487K
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$13
14%
upside
Avg. target
$14
22%
upside
High target
$15
31%
upside
2 analyst ratings
0 positive
0%
2 neutral
100%
0 negative
0%
Citigroup Scott Gruber | 14%upside $13 | Neutral Maintained | 13 May 2025 |
Stifel Stephen Gengaro | 31%upside $15 | Hold Maintained | 15 Apr 2025 |
Financial journalist opinion
Based on 9 articles about CLB published over the past 30 days
Negative
Zacks Investment Research
5 days ago
Core Laboratories Down 30% YTD: Should You Hold or Sell the Stock?
CLB struggles with a 4.4% revenue decline, low ROIC in the first quarter of 2025, minimal dividends and vulnerability to oil price volatility and geopolitical instability.
Negative
Zacks Investment Research
6 days ago
New Strong Sell Stocks for May 14th
AMTB, CLB and EXPI have been added to the Zacks Rank #5 (Strong Sell) List on May 14, 2025.
Neutral
PRNewsWire
1 week ago
CORE LABORATORIES ANNOUNCES OPENING OF UNCONVENTIONAL CORE ANALYSIS LABORATORY IN SAUDI ARABIA
HOUSTON , May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia. This state-of-the-art facility, developed in collaboration with Core's long-time partner, Abdulla Fouad Group, underscores the Company's commitment to advancing reservoir evaluation technologies in the Middle East.
Negative
Zacks Investment Research
3 weeks ago
Core Laboratories Q1 Earnings Miss Estimates, Expenses Increase YoY
CLB's first-quarter earnings miss estimates due to the underperformance of the Reservoir Description segment.
Neutral
Seeking Alpha
3 weeks ago
Core Laboratories Inc. (CLB) Q1 2025 Earnings Call Transcript
Core Laboratories Inc. (NYSE:CLB ) Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Sean Mitchell - Daniel Energy Partners Operator Good day, and welcome to the Core Laboratories First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Negative
Zacks Investment Research
3 weeks ago
New Strong Sell Stocks for April 24th
AMPY, CARS and CLB have been added to the Zacks Rank #5 (Strong Sell) List on April 24, 2025.
Negative
Zacks Investment Research
3 weeks ago
Core Laboratories (CLB) Q1 Earnings and Revenues Lag Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.19 per share a year ago.
Neutral
PRNewsWire
3 weeks ago
CORE LAB REPORTS FIRST QUARTER 2025 RESULTS
REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAR OPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEAR FREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON , April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,600,000. Core's operating income was $4,400,000, with earnings per diluted share ("EPS") of $0.00, all in accordance with U.S. generally accepted accounting principles ("GAAP").
Positive
Zacks Investment Research
4 weeks ago
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
CLB's first-quarter revenues are likely to have declined from the year-ago period's level. However, cost reductions are expected to have provided modest relief.
Negative
Zacks Investment Research
1 month ago
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Charts implemented using Lightweight Charts™